161 related articles for article (PubMed ID: 24565737)
1. Operational assessments of Sayana® Press provision in Senegal and Uganda.
Cover J; Blanton E; Ndiaye D; Walugembe F; Lamontagne DS
Contraception; 2014 May; 89(5):374-8. PubMed ID: 24565737
[TBL] [Abstract][Full Text] [Related]
2. Provider acceptability of Sayana® Press: results from community health workers and clinic-based providers in Uganda and Senegal.
Burke HM; Mueller MP; Packer C; Perry B; Bufumbo L; Mbengue D; Daff BM; Mbonye A
Contraception; 2014 May; 89(5):368-73. PubMed ID: 24576792
[TBL] [Abstract][Full Text] [Related]
3. Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal.
Burke HM; Mueller MP; Perry B; Packer C; Bufumbo L; Mbengue D; Mall I; Daff BM; Mbonye AK
Contraception; 2014 May; 89(5):361-7. PubMed ID: 24631328
[TBL] [Abstract][Full Text] [Related]
4. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
Polis CB; Nakigozi GF; Nakawooya H; Mondo G; Makumbi F; Gray RH;
Contraception; 2014 May; 89(5):385-95. PubMed ID: 24332432
[TBL] [Abstract][Full Text] [Related]
5. Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal.
Di Giorgio L; Mvundura M; Tumusiime J; Namagembe A; Ba A; Belemsaga-Yugbare D; Morozoff C; Brouwer E; Ndour M; Drake JK
Contraception; 2018 Nov; 98(5):389-395. PubMed ID: 29859148
[TBL] [Abstract][Full Text] [Related]
6. Perceptions of home and self-injection of Sayana® Press in Ethiopia: a qualitative study.
Keith B; Wood S; Chapman C; Alemu E
Contraception; 2014 May; 89(5):379-84. PubMed ID: 24529492
[TBL] [Abstract][Full Text] [Related]
7. Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda.
MacLachlan E; Atuyambe LM; Millogo T; Guiella G; Yaro S; Kasasa S; Bukenya J; Nyabigambo A; Mubiru F; Tumusiime J; Onadja Y; Zan LM; Goeum/Sanon C; Kouanda S; Namagembe A
Contraception; 2018 Nov; 98(5):423-429. PubMed ID: 30125558
[TBL] [Abstract][Full Text] [Related]
8. Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda.
Odwe G; Gray K; Kyarimpa A; Obare F; Nagendi G
Glob Health Sci Pract; 2018 Dec; 6(4):711-722. PubMed ID: 30429201
[TBL] [Abstract][Full Text] [Related]
9. Home-based administration of Sayana® Press: review and assessment of needs in low-resource settings.
Keith B; Wood S; Tifft S; Hutchings J
Contraception; 2014 May; 89(5):344-51. PubMed ID: 24813924
[TBL] [Abstract][Full Text] [Related]
10. Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries.
Stout A; Wood S; Barigye G; Kaboré A; Siddo D; Ndione I
Glob Health Sci Pract; 2018 Mar; 6(1):55-72. PubMed ID: 29602866
[TBL] [Abstract][Full Text] [Related]
11. Adolescent and covert family planning users' experiences self-injecting contraception in Uganda and Malawi: implications for waste disposal of subcutaneous depot medroxyprogesterone acetate.
Burke HM; Packer C; Wando L; Wandiembe SP; Muwereza N; Pradhan S; Zingani A; Ngwira B
Reprod Health; 2020 Aug; 17(1):117. PubMed ID: 32746860
[TBL] [Abstract][Full Text] [Related]
12. Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda.
Cover J; Namagembe A; Tumusiime J; Nsangi D; Lim J; Nakiganda-Busiku D
Contraception; 2018 Nov; 98(5):383-388. PubMed ID: 29654751
[TBL] [Abstract][Full Text] [Related]
13. Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda.
Di Giorgio L; Mvundura M; Tumusiime J; Morozoff C; Cover J; Drake JK
Contraception; 2018 Nov; 98(5):396-404. PubMed ID: 30098940
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort study.
Cover J; Ba M; Lim J; Drake JK; Daff BM
Contraception; 2017 Sep; 96(3):203-210. PubMed ID: 28673645
[TBL] [Abstract][Full Text] [Related]
15. A prospective cohort study to assess the acceptability of Sayana Press among 18-49-year-old women in Nepal.
Sherpa LY; Tinkari BS; Gentle P; Sah RK; Shrestha A; Sahani SK; Aryal K; Ghimire J; Karki DK
Contraception; 2021 Dec; 104(6):623-627. PubMed ID: 34280441
[TBL] [Abstract][Full Text] [Related]
16. Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC).
Stout A; Wood S; Namagembe A; Kaboré A; Siddo D; Ndione I
Eval Program Plann; 2018 Jun; 68():185-193. PubMed ID: 29609057
[TBL] [Abstract][Full Text] [Related]
17. Getting closer to people: family planning provision by drug shops in Uganda.
Akol A; Chin-Quee D; Wamala-Mucheri P; Namwebya JH; Mercer SJ; Stanback J
Glob Health Sci Pract; 2014 Nov; 2(4):472-81. PubMed ID: 25611480
[TBL] [Abstract][Full Text] [Related]
18. Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results.
Okegbe T; Affo J; Djihoun F; Zannou A; Hounyo O; Ahounou G; Bangbola KA; Harris N
Glob Health Sci Pract; 2019 Jun; 7(2):228-239. PubMed ID: 31171559
[TBL] [Abstract][Full Text] [Related]
19. A prospective cohort study of the feasibility and acceptability of depot medroxyprogesterone acetate administered subcutaneously through self-injection.
Cover J; Namagembe A; Tumusiime J; Lim J; Drake JK; Mbonye AK
Contraception; 2017 Mar; 95(3):306-311. PubMed ID: 27789309
[TBL] [Abstract][Full Text] [Related]
20. Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi.
Burke HM; Packer C; Buluzi M; Healy E; Ngwira B
Contraception; 2018 Nov; 98(5):405-410. PubMed ID: 29706227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
